publicaciones seleccionadas
-
documento
- HSD105 Cost Savings Benefits of Operational Waste Minimization in a Care Program by Cohorts of Babies on Treatment With Palivizumab
- HSD23 Operational Waste Savings on Health in a Value-Based Patient Drug Safety Program
- HSD38 Operational Savings Generated in an Integrated Care Program for Patients with Complex Respiratory Diseases
- HSD43 Waste Savings on Health in a Value-Based Drug Safety Program in Patients with Chronic High-Cost Diseases
- HSD69 Cost Savings of Waste on Health by Pharmacological Inefficiencies in a Value-Based Patient Drug Safety Program
- HSD92 Operational Savings Generated in an Integrated Care Clinic for Immune-Mediated Skin Disorders
- POSA395 Operational Waste Management Model Articulated Between Insurer Health and Pharmaceutical Benefit Manager
- POSB399 Systematic Identification of Pharmacological Inefficiencies By a Value-Based Patient Drug Safety Program